1. Smith RD, Sweet CS, Goldberg A, Timmermans PBMWM. Losartan potassium: a non peptide antagonist of angiotensin II.Drugs of today.1995; 31 (7): 463–98.
2. Criscione L, Bradley WA, BUhlmayer P, White-bread S.Glazer R, Lloyd P, Mueller P, De Gasparo M. Valsartan: preclinical and clinical profile of an antihypertensive angiotensin II antagonist.Cardiovascular Drugs Reviews.1995; 13 (3): 230–50.
3. Critchley JAJH, Gilchrest N, Ikeda L et al. A randomized, double-masked comparison of the antihypertensive efficacy and safety of combination therapy with losartan and hydrochlorothiazide versus captopril and hydrochlorothiazide in elderly and younger patients.Cur Ther Res.1996; 57 (5): 392–407.
4. Crazier I, Kram H, Ausen N, Cleland J, Stephen S, Dickstein K. Losartan in heart failure. Hemodynamic efTects and tolerability.Circulation.1995; 91 • 691–7.
5. Pitt B, Dickstein K, Benedict C, Pacher R.Willen-heimer R, Murali S, Dunlay M, Chang P, Grossman W. The Randomized Angiotensin Receptor Antagonist-ACE Inhibitor Study (RAAS)-Pilot Study.Circulation.1996; 94 (8): 2497.